1. Nobile CJ, Johnson ADJArom. Candida albicans biofilms and human disease. 2015;69:71-92.
2. Waller JCJS. The Kingdom of Plants. 2008;322(5903):860-.
3. Singh A, Ahmad I, Akhter S, Jain GK, Iqbal Z, Talegaonkar S, et al. Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies. 2013;102:822-32.
4. Abdel-Fattah A-FM, Matsumoto K, Watanabe HJEjop. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. 2000;400(1):89-97.
5. Nemmar A, Al‐Salam S, Zia S, Marzouqi F, Al‐Dhaheri A, Subramaniyan D, et al. Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone. 2011;164(7):1871-82.
6. Raghunandhakumar S, Paramasivam A, Senthilraja S, Naveenkumar C, Asokkumar S, Binuclara J, et al. Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma. 2013;223(1):60-72.
7. Erboga M, Kanter M, Aktas C, Sener U, Erboga ZF, Donmez YB, et al. Thymoquinone ameliorates cadmium-induced nephrotoxicity, apoptosis, and oxidative stress in rats is based on its anti-apoptotic and anti-oxidant properties. 2016;170(1):165-72.
8. Awad AS, Abd Al Haleem EN, El-Bakly WM, Sherief MAJN-Ssaop. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. 2016;389(4):381-91.
9. Liu H, Liu HY, Jiang YN, Li NJMmr. Protective effect of thymoquinone improves cardiovascular function, and attenuates oxidative stress, inflammation and apoptosis by mediating the PI3K/Akt pathway in diabetic rats. 2016;13(3):2836-42.
10. Khader M, Eckl P, Bresgen NJJoe. Effects of aqueous extracts of medicinal plants on MNNG-treated rat hepatocytes in primary cultures. 2007;112(1):199-202.
11. Simon H-U, Haj-Yehia A, Levi-Schaffer FJA. Role of reactive oxygen species (ROS) in apoptosis induction. 2000;5(5):415-8.
12. Shukla R, Cheryan MJIc, products. Zein: the industrial protein from corn. 2001;13(3):171-92.
13. Zhang Y, Cui L, Chen Y, Zhang H, Zhong J, Sun Y, et al. Zein-based nanofibres for drug delivery: classes and current applications. 2015;21(22):3199-207.
14. Lai L, Guo HJIjop. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. 2011;404(1-2):317-23.
15. Wayne PJCdM-A. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. 2002.
16. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MAJJob. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. 2001;183(18):5385-94.
17. Motavalli M, Khodadadi I, Fallah M, Maghsood AHJPr. Effect of oxidative stress on vital indicators of Acanthamoeba castellanii (T4 genotype). 2018;117(9):2957-62.
18. Nikoomanesh F, Roudbarmohammadi S, Khoobi M, Haghighi F, Roudbary MJAc, nanomedicine,, biotechnology. Design and synthesis of mucoadhesive nanogel containing farnesol: investigation of the effect on HWP1, SAP6 and Rim101 genes expression of Candida albicans in vitro. 2019;47(1):64-72.
19. De Rosa FG, Corcione S, Filippini C, Raviolo S, Fossati L, Montrucchio C, et al. The effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards. 2015;10(5):e0125149.
20. Canela HMS, Cardoso B, Vitali LH, Coelho HC, Martinez R, Ferreira MEdSJM. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. 2018;61(1):11-21.
21. Tumbarello M, Posteraro B, Trecarichi EM, Fiori B, Rossi M, Porta R, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 2007;45(6):1843-50.
22. Ramage G, Martínez JP, López-Ribot JLJFyr. Candida biofilms on implanted biomaterials: a clinically significant problem. 2006;6(7):979-86.
23. Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JLJJoAC. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. 2002;49(6):973-80.
24. Moghim H, Taghipoor S, Shahinfard N, Kheiri S, Panahi RJJoHP. Antifungal effects of Zataria multiflora and Nigella sativa extracts against Candida albicans. 2015;4.
25. Najee H, Kamerzan C, Marutescu L, Gheorghe I, Popa M, Gradisteanu G, et al. Antifungal activity of some medicinal plant extracts against Candida albicans nosocomial isolates. 2018;23(6):14073-6.
26. Almshawit H, Macreadie IJMr. Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata. 2017;195:81-8.
27. Randhawa MA, Gondal MA, Al-Zahrani A-HJ, Rashid SG, Ali AJJoES, Health PA. Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm. 2015;50(2):119-24.
28. Bhattacharjee M, Upadhyay P, Sarker S, Basu A, Das S, Ghosh A, et al. Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer. 2020;1864(11):129695.
29. Bhattacharya S, Ahir M, Patra P, Mukherjee S, Ghosh S, Mazumdar M, et al. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. 2015;51:91-107.
30. İşcan G, İşcan A, Demirci FJNpc. Anticandidal effects of thymoquinone: Mode of action determined by transmission electron microscopy (TEM). 2016;11(7):1934578X1601100726.
31. El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M, et al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. 2010;15(2):183-95.